Page last updated: 2024-08-23

fenoxycarb and Pulmonary Disease, Chronic Obstructive

fenoxycarb has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Ahaus, K; Noort, BAC; van der Vaart, T1
Hu, H; Lin, G; Tang, PK; Ung, COL; Zheng, J; Zheng, Y1
Hu, H; Hu, Y; Ung, COL; Yao, D1

Reviews

2 review(s) available for fenoxycarb and Pulmonary Disease, Chronic Obstructive

ArticleYear
Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model.
    International journal of chronic obstructive pulmonary disease, 2022, Volume: 17

    Topics: Hospitals; Humans; Logic; Pharmacists; Pulmonary Disease, Chronic Obstructive; Quality of Life

2022
Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.
    International journal of chronic obstructive pulmonary disease, 2020, Volume: 15

    Topics: Community Pharmacy Services; Humans; Logic; Pharmacies; Pharmacists; Professional Role; Pulmonary Disease, Chronic Obstructive; Quality of Life

2020

Other Studies

1 other study(ies) available for fenoxycarb and Pulmonary Disease, Chronic Obstructive

ArticleYear
Orchestration versus bookkeeping: How stakeholder pressures drive a healthcare purchaser's institutional logics.
    PloS one, 2021, Volume: 16, Issue:10

    Topics: Delivery of Health Care; Humans; Interviews as Topic; Logic; Pulmonary Disease, Chronic Obstructive; Stakeholder Participation

2021